Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Normal Saline Versus Heparin Intermittent Flushing for the Prevention of Occlusion in Port-a-Cath
NCT05707936Completed
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Feb 2023
- Primary completion
- Oct 2023
- Countries
- 1
01
Overview
Randomised, single-blind trial of Normal Saline-Benha University (3 arms), sponsored by Chang Gung Memorial Hospital. Primary endpoints: Number of participants with TIVAD (Port-a-Cath) occlusion at 30 days and Number of participants with catheter-related bloodstream infection at 30 days. Started Feb 2023; status: completed.
02
Drugs
Normal Saline-Benha University
Beyond the preview
Go deeper on NCT05707936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05707936.